Skip to main content
Clinical Trials/NCT07740746
NCT07740746CompletedNot Applicable

A Study to Evaluate the Effects of a Supplement on Mucus Clearance and Respiratory Symptoms

The Better Brand Inc.1 site in 1 country100 target enrollmentStarted: April 22, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
Change in mucus clearance

Study Overview

Brief Summary

This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of the BetterLungs Mullein + Chlorophyll supplement on mucus clearance and respiratory symptoms over 60 days. One hundred adult participants experiencing chest mucus build-up, difficulty clearing mucus, breathlessness, and low energy levels will be enrolled and randomized to either the active supplement or a matched placebo.

Participants will take their assigned product once daily in the morning mixed with water and will complete self-reported questionnaires at Baseline, Day 20, Day 40, and Day 60.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Triple (Participant, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Be male or female
  • Be aged 18+
  • Anyone experiencing issues regarding all of the following over the past three months: a build-up of chest mucus, difficulty clearing chest mucus, breathlessness, and low energy levels
  • Anyone who is generally healthy - does not live with any uncontrolled chronic disease
  • Willing to refrain from taking any products, prescription medications, or supplements that target lung health, mucus, and energy levels during the test period
  • Willing to maintain your current diet, sleep schedule, and activity level for the duration of the study
  • Resides in the United States
  • Not currently partaking in another research study and will not be partaking in any other research study for the next 60 days and at any point during this study's duration
  • If currently taking prescription medication are willing to discuss it with their physician before participating in this study

Exclusion Criteria

  • Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including kidney disease, diabetes, cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period
  • Anyone who drinks heavily (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men)
  • Anyone with a copper sensitivity disorder (such as Wilson's disease or copper metabolism disorders)
  • Anyone with kidney disease
  • Anyone with diabetes
  • Anyone with any known allergies or hypersensitivities to any supplement product ingredients
  • Anyone who is currently pregnant, trying to conceive, or breastfeeding

Outcomes

Primary Outcomes

Change in mucus clearance

Time Frame: Baseline, Day 20, Day 40, and Day 60

Self-reported change in mucus clearance assessed via questionnaire

Change in respiratory symptoms

Time Frame: Baseline, Day 20, Day 40, and Day 60

Self-reported change in respiratory symptoms assessed via questionnaire

Secondary Outcomes

  • Change in perceived mucus clearance(Baseline, Day 20, Day 40, and Day 60)
  • Change in energy levels(Baseline, Day 20, Day 40, and Day 60)
  • Change in shortness of breath(Baseline, Day 20, Day 40, and Day 60)
  • Change in breathing-related anxiety(Baseline, Day 20, Day 40, and Day 60)
  • Change in ease of breathing(Baseline, Day 20, Day 40, and Day 60)
  • Change in general well-being(Baseline, Day 20, Day 40, and Day 60)

Investigators

Sponsor
The Better Brand Inc.
Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials